Recent insight into the behavior of blood R1 and R2* predicts the precise manner that signal intensity increases, plateaus, and ultimately diminishes with increasing gadolinium-based contrast agent concentration ([GBCA]). This has important implications for optimal GBCA utilization and administration in contrast enhanced MRA (CE-MRA). We validate these theoretical constructs in an in vivo pig model where time resolved CE-MRA and [GBCA] (via mass spectrometry) are acquired simultaneously, demonstrating that the theoretical relationship between [GBCA] and R1, R2* as applied to first pass CE-MRA allows for accurate predictions of CE-MRA signal intensity for any given blood concentration across three different GBCAs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords